Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y...
Cencora’s first quarter results came in below Wall Street’s revenue expectations, and the market responded negatively. Management pointed to several factors ...
Cencora (NYSE:COR) reported higher fiscal second-quarter adjusted earnings and operating income, while management raised its full-year adjusted EPS outlook and said it would resume opportunistic share repurchases. The pharmaceutical distribution and healthcare services company also lowered its full-
Healthcare distributor Cencora (NYSE:COR) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $78.36 billion. Its non-G...
Healthcare distributor Cencora (NYSE:COR) will be reporting results this Wednesday before market open. Here’s what you need to know. Cencora missed analysts’...
Over the last six months, Cencora’s shares have sunk to $312.06, producing a disappointing 6.3% loss - a stark contrast to the S&P 500’s 4% gain. This may ha...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...
In the complex, high-stakes machinery of the American healthcare system, few companies are as indispensable—yet as quietly influential—as McKesson Corporation (NYSE: MCK). As of March 18, 2026, McKesson stands not merely as a distributor of pills and medical supplies, but as a sophisticated healthcare services platform that has successfully pivoted from low-margin logistics to high-value [...]
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
